Skip to main navigation Skip to search Skip to main content

Corrigendum: Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study(Front. Cardiovasc. Med., (2021), 8, (785109), 10.3389/fcvm.2021.785109)

  • Michael C. Wang
  • , Bridget Dolan
  • , Benjamin H. Freed
  • , Lourdes Vega
  • , Nikola Markoski
  • , Amy E. Wainright
  • , Bonnie Kane
  • , Laura E. Seegmiller
  • , Katharine Harrington
  • , Alana A. Lewis
  • , Sanjiv J. Shah
  • , Clyde W. Yancy
  • , Ian J. Neeland
  • , Hongyan Ning
  • , Donald M. Lloyd-Jones
  • , Sadiya S. Khan
  • Northwestern University
  • Case Western Reserve University

Research output: Contribution to journalComment/debate

Abstract

In the original article, there was a mistake in Figure 2 (Pharmacist-directed intervention treatment algorithm) as published. The decision tree boxes “African American OR ACE inh intolerant” and “Not African American AND ACE inh tolerant” were reversed, and the abbreviation “ACE inh” instead of “ACEi” was used. The corrected Figure 2 (Pharmacist-directed intervention treatment algorithm) appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original languageEnglish
Article number844270
JournalFrontiers in Cardiovascular Medicine
Volume9
DOIs
StatePublished - Feb 18 2022

Keywords

  • heart failure
  • natriuretic peptides
  • pharmacist
  • primary prevention
  • risk prediction

Fingerprint

Dive into the research topics of 'Corrigendum: Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study(Front. Cardiovasc. Med., (2021), 8, (785109), 10.3389/fcvm.2021.785109)'. Together they form a unique fingerprint.

Cite this